Aarti Drugs Ltd (BOM:524348)
₹ 480.2 6.1 (1.29%) Market Cap: 44.15 Bil Enterprise Value: 49.58 Bil PE Ratio: 24.85 PB Ratio: 3.31 GF Score: 91/100

Q1 2022 Aarti Drugs Ltd Earnings Call Transcript

Jul 27, 2021 / NTS GMT
Release Date Price: ₹719.9 (-0.37%)
Operator

I now hand the conference over to Mr. Adhish Patil, CFO, Aarti Drugs Limited.

Thank you and over to you sir.

Adhish Patil
Aarti Drugs Limited - CFO

Thank you. Hello everyone, and a very warm welcome to all of you present on the call to discuss our financial results for the first quarter of financial year 2022. So from Aarti Drugs Limited today we have our Joint Managing Director, Mr. Harshit Savla, then whole time Director Mr. Harit Shah, and myself CFO of the company.

We hope all of you and your loved ones are healthy and safe in the wake of ongoing pandemic answers across the country. The downward trend of COVID-19 cases is certainly a good sign. And we sincerely hope that the pandemic gets over soon, I would also like to highlight that the company has not faced any major disruption in terms of supply chain or plant shutdowns due to ongoing flood situation in Maharashtra.

We are happy to share that Aarti Drugs delivered a resilient performance despite facing multiple headwinds during the quarter, our consolidated revenue stood at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot